Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Share News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

Share Price is delayed by 15 minutes
Get Live Data
22.50    0.10 (0.44%)
Bid:
22.00
Ask:
23.00
Spread: 1.00 (4.545%)
Market Cap: £234.54m
SCLP Live PriceLast checked at - London Stock Exchange

Intraday Scancell Holdings Share Chart

Scancell Holdings News

WINNERS & LOSERS: Indonesia curbs hit MP Evans; S&U rises
20 May 2026

WINNERS & LOSERS: Indonesia curbs hit MP Evans; S&U rises

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Wednesday.

TRADING UPDATES: Conduit CFO Whelan to step down in September
28 Apr 2026

TRADING UPDATES: Conduit CFO Whelan to step down in September

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported...

IN BRIEF: Scancell names David Schilansky as interim finance chief
2 Apr 2026

IN BRIEF: Scancell names David Schilansky as interim finance chief

Scancell Holdings PLC - Oxford-based pharmaceutical company focused on cancer immunotherapies - Appoints "highly experienced senior healthcare executi...

EARNINGS AND TRADING: Pinewood Tech gets bid approach from Apax
29 Jan 2026

EARNINGS AND TRADING: Pinewood Tech gets bid approach from Apax

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...

EARNINGS AND TRADING: Scancell gets FDA clearance for phase 3 trial
26 Jan 2026

EARNINGS AND TRADING: Scancell gets FDA clearance for phase 3 trial

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported...

FDA clears Scancell's application for phase three trial
26 Jan 2026

FDA clears Scancell's application for phase three trial

(Sharecast News) - Scancell said on Monday that the US Food and Drug Administration had cleared its investigational new drug application for a registr...

Scancell reports further data from DNA cancer immunotherapy trial
9 Dec 2025

Scancell reports further data from DNA cancer immunotherapy trial

(Sharecast News) - Scancell reported further positive clinical data for its DNA cancer immunotherapy iSCIB1+, on Tuesday, saying updated phase two res...